Mitchell H. Rosner

Mitchell Rosner practices at UVA University Medical Center in Charlottesville, Virginia.

Mitchell Rosner's NPI, 1164591707, was assigned on November 7, 2006. Mitchell Rosner graduated from Medical College of Georgia School of Medicine in 1996. Mitchell Rosner holds Virginia license 0101056223.

Mitchell Rosner's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Mitchell Rosner's primary practice is UVA University Medical Center in Charlottesville, Virginia. Mitchell Rosner is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Mitchell Rosner to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mitchell Rosner practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Mitchell Rosner's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Mitchell Rosner is licensed in Virginia.

CMS data shows 445 Medicare services from Mitchell Rosner across 7 procedure codes in 2024, for 209 Medicare patients. Medicare paid $34,164 for them.

CMS counts 209 Medicare patients who saw Mitchell Rosner in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mitchell Rosner's median patient age at 65, with 54% women.

In 2024, Mitchell Rosner wrote 249 Medicare Part D claims for 57 patients. 95% of them were for generic drugs. CMS names the drug for 113 of them, across 7 drugs with 11 or more claims each, at $21,528 in total drug cost. In 2023, CMS named 179 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Mitchell Rosner for performance year 2024, reported as part of a group. Mitchell Rosner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 62 papers to Mitchell Rosner, published from 2018 to 2025. 2023 was the busiest year, with 11. The most frequent topics are Acute Kidney Injury, Renal Insufficiency, Chronic and Renal Dialysis. Mitchell Rosner has published most often in Clin J Am Soc Nephrol. Mitchell Rosner's most frequent co-authors are Mark A. Perazella, MD, Ravindra L. Mehta, MD and Sabine Karam, MD.

Dmand AI links Mitchell Rosner to 1 clinical trial. Conditions studied include Diabetic Nephropathies and Diabetes Complications. Open Payments lists research payments to Mitchell Rosner that name 1 trial.

CMS Open Payments shows 104 general payments to Mitchell Rosner from 13 drug and device companies from 2016 to 2024. Grants make up the largest share, 46% of the total. Medtronic Vascular, Inc. paid the most, $84,706. It also lists 6 research payments totaling $9,763 from 2016 to 2020, naming 1 clinical trial.

Mitchell Rosner graduated from Medical College of Georgia School of Medicine in 1996.